Vaccination against bubonic and pneumonic plague (Q34310210)

1 August 2017

1 reference

title

Vaccination against bubonic and pneumonic plague (English)

1 reference

1 August 2017

Titball RW

1

1 reference

PubMed ID

11457543

1 August 2017

Williamson ED

series ordinal

2

1 reference

PubMed ID

11457543

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

1 August 2017

1 reference

1 August 2017

19

1 reference

1 August 2017

4175-4184

1 reference

1 August 2017

30

1 reference

Factors promoting acute and chronic diseases caused by yersiniae

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Surveillance for pneumonic plague in the United States during an international emergency: a model for control of imported emerging diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Multidrug resistance in Yersinia pestis mediated by a transferable plasmid

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Plague Immunization. V. Indirect Evidence for the Efficacy of Plague Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Intracellular multiplication and virulence of Shigella flexneri auxotrophic mutants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Gene expression and the development of live enteric vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

1993 Colworth Prize Lecture. The molecular basis for the virulence of bacterial pathogens: implications for oral vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Potency testing of a live, genetically attenuated vaccine for salmonids.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Auxotrophic Salmonella typhi as live vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Virulence and vaccine potential of phoP mutants of Salmonella typhimurium.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

A Brucella melitensis high-temperature-requirement A (htrA) deletion mutant is attenuated in goats and protects against abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

An aroA mutant of Yersinia pestis is attenuated in guinea-pigs, but virulent in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

The response regulator PhoP is important for survival under conditions of macrophage-induced stress and virulence in Yersinia pestis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Investigation into the role of the serine protease HtrA in Yersinia pestis pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Characterization of the lipopolysaccharide of Yersinia pestis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Yersinia outer proteins (YOPS) E, K and N are antigenic but non-protective compared to V antigen, in a murine model of bubonic plague

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Effect of Yersinia pestis YopM on experimental plague

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Molecular analysis of lcrGVH, the V antigen operon of Yersinia pestis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Virulence genes regulated at the transcriptional level by Ca2+ in Yersinia pestis include structural genes for outer membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Local and systemic immune response to a microencapsulated sub-unit vaccine for plague

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Analysis of the Yersinia pestis V protein for the presence of linear antibody epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Studies on the co-encapsulation, release and integrity of two subunit antigens: rV and rF1 from Yersinia pestis.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Intra nasal administration of poly-lactic acid microsphere co-encapsulated Yersinia pestis subunits confers protection from pneumonic plague in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Generation of protective immune responses to plague by mucosal administration of microsphere coencapsulated recombinant subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Chitosan as a novel nasal delivery system for peptide drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Comparison of the immunological and protective responses elicited by microencapsulated formulations of the F1 antigen from Yersinia pestis

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Antibody responses to Yersinia pestis F1-antigen expressed in Salmonella typhimurium aroA from in vivo-inducible promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

Expression of an F1/V fusion protein in attenuated Salmonella typhimurium and protection of mice against plague

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900163-3

7 January 2021

10.1016/S0264-410X(01)00163-3

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11457543